Lovastatin Inhibits Cancer Stem Cells and Sensitizes to Chemo- and Photodynamic Therapy in Nasopharyngeal Carcinoma.

Lovastatin Inhibits Cancer Stem Cells and Sensitizes to Chemo- and Photodynamic Therapy in Nasopharyngeal Carcinoma.
复制标题

DOI:
10.7150/jca.19100
复制
发表时间:
2017
期刊:
影响因子:
3.9
通讯作者:
Deng X
Deng X
中科院分区:
医学3区
文献类型:
--
作者:
Peng Y;He G;Tang D;Xiong L;Wen Y;Miao X;Hong Z;Yao H;Chen C;Yan S;Lu L;Yang Y;Li Q;Deng X

文献摘要

参考文献

被引文献

相似文献

鼻咽癌是一种与EB病毒相关的恶性肿瘤,在东南亚和中国南部高发。尽管鼻咽癌患者早期对放化疗有良好的反应,但在晚期鼻咽癌患者中会出现耐药性和复发。肿瘤干细胞(CSCs)在肿瘤耐药和肿瘤复发中起重要作用。洛伐他汀是一种天然化合物,也是一种亲脂性的他汀类药物,已在临床上用于治疗高胆固醇血症,我们报道了洛伐他汀抑制5-8F和6-10B鼻咽癌细胞系球状细胞的CSC特性,并诱导其凋亡和细胞周期停滞。此外,洛伐他汀可增强鼻咽癌干细胞对化疗药物和光动力药物的敏感性。综上所述,我们的研究结果表明,洛伐他汀联合常规化疗药物或光动力疗法靶向CSCs可能是治疗鼻咽癌的一种有前途的方法。
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus-associated malignancy occurring at high incidence in Southeast Asia and southern China. In spite of the good response to radio- and chemo-therapy at the early stage, resistance and recurrence develop in NPC patients in the advanced setting. Cancer stem cells (CSCs) play an important role in drug resistance and cancer recurrence. Here we report that lovastatin, a natural compound and a lipophilic statin that has already been used in the clinic to treat hypercholesterolemia, inhibited the CSC properties and induced apoptosis and cell cycle arrest in sphere-forming cells derived from the 5-8F and 6-10B NPC cell lines. Furthermore, lovastatin conferred enhanced sensitivity to the chemotherapeutic and photodynamic agents in NPC CSCs. Together our findings suggest that targeting CSCs by lovastatin in combination with routine chemotherapeutic drugs or photodynamic therapy might be a promising approach to the treatment of NPC.
DOI: 10.3322/caac.20114
发表时间: 2011-07
期刊: CA: a cancer journal for clinicians
影响因子: --
作者:
Agostinis P;Berg K;Cengel KA;Foster TH;Girotti AW;Gollnick SO;Hahn SM;Hamblin MR;Juzeniene A;Kessel D;Korbelik M;Moan J;Mroz P;Nowis D;Piette J;Wilson BC;Golab J
通讯作者: Golab J
通过植物化学物质靶向癌症干细胞和信号通路:乳腺癌治疗的新方法。
DOI: 10.1016/j.semcancer.2016.09.001
发表时间: 2016-10
影响因子: 14.5
作者:
Dandawate PR;Subramaniam D;Jensen RA;Anant S
通讯作者: Anant S
DOI: 10.1002/pros.21131
发表时间: 2010-06-15
期刊: PROSTATE
影响因子: 2.8
作者:
Parikh, Ankur;Childress, Chandra;Yang, Wannian
通讯作者: Yang, Wannian
DOI: 10.4103/0973-1482.146127
发表时间: 2016-04-01
影响因子: 1.3
作者:
Afzali, Monireh;Vatankhah, Melody;Ostad, Seyed Nasser
通讯作者: Ostad, Seyed Nasser
DOI: 10.1016/j.ccr.2012.03.003
发表时间: 2012-03-20
期刊: Cancer cell
影响因子: 50.3
作者:
Magee JA;Piskounova E;Morrison SJ
通讯作者: Morrison SJ